🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the efficacy of 400 mg Q...
Status
Completed
Location
1100.1486.0040 Boehringer Ingelheim Investigational Site
Start Date
2007-11
Trial ID
NCT00561925
Treatments Being Tested
Study to determine the pharmacokinetic properties of 200 mg (2 x 100 mg tab...
Status
Completed
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT02184312
Treatments Being Tested
The primary objective of this study is to demonstrate the efficacy of nevir...
Status
Completed
Location
1100.1526.1012 Boehringer Ingelheim Investigational Site
Start Date
2008-12
Trial ID
NCT00819052
Treatments Being Tested
The primary objective is to establish the pharmacokinetic (PK) profile at s...
Status
Completed
Location
1100.1518.0001 Boehringer Ingelheim Investigational Site
Start Date
2009-06
Trial ID
NCT00905489
Treatments Being Tested
The objective was to establish the pharmacokinetic (PK) profile at steady s...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT02194179
Study to determine the pharmacokinetic properties of 200 mg nevirapine (NVP...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT02194218
Treatments Being Tested